OverviewSuggest Edit

Nuvaira develops devices for treating lung diseases. The Company is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease.

TypePrivate
Founded2008
HQPlymouth, MN, US
Websitenuvaira.com

Latest Updates

Employees (est.) (Jun 2021)51(+7%)
Cybersecurity ratingAMore

Key People/Management at Nuvaira

Jon Root

Jon Root

Director
Gary Rieschel

Gary Rieschel

Director
Mike Carusi

Mike Carusi

Director
Hank Plain

Hank Plain

Director
Tim Herbert

Tim Herbert

Director
Carolyn Ng

Carolyn Ng

Director
Show more

Nuvaira Office Locations

Nuvaira has offices in Plymouth and Maple Grove
Plymouth, MN, US (HQ)
3750 Annapolis Ln N #105
Maple Grove, MN, US
6500 Wedgwood Rd N #100
Show all (2)

Nuvaira Financials and Metrics

Summary Metrics

Founding Date

2008

Nuvaira total Funding

$147.6 m

Nuvaira latest funding size

$79 m

Time since last funding

2 years ago

Nuvaira investors

Nuvaira's latest funding round in February 2019 was reported to be $79 m. In total, Nuvaira has raised $147.6 m
Show all financial metrics

Nuvaira Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Nuvaira Online and Social Media Presence

Embed Graph

Nuvaira News and Updates

Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone

Seasoned Veteran Tom Griffin Joins Nuvaira's Executive Team MINNEAPOLIS, Feb. 4, 2020 /PRNewswire/ -- Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that Tom Griffin has joined Nuvaira as Chief Financial Officer. Tom Griffin has a...

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology...

Nuvaira Blogs

Nuvaira Announces Published Two-Year Results in COPD Patients treated with Targeted Lung Denervation

AIRFLOW-2 two-year data confirm sustained reduction of severe COPD exacerbation risk vs. a control group. MINNEAPOLIS, Nov. 23, 2020 /PRNewswire/ — Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today publication of two-year follow-up data from its…

Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device

Inspire Medical Systems CEO Tim Herbert has joined Nuvaira Board of Directors MINNEAPOLIS, June 8, 2020 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that its Nuvaira® Lung Denervation System has been designated as a Breakthrough Device by t…

Nuvaira Announces Peer-Reviewed Publications of Targeted Lung Denervation Mechanisms of Action and Clinical Outcomes

AIRFLOW-2 randomized, sham-controlled one-year data accepted by AJRCCM MINNEAPOLIS, Aug 19, 2019 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today multiple peer-reviewed publications that provide further evidence of the safety, clinical effect…

First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

A first for Temple University Hospital and U.S. Patients MINNEAPOLIS, June 10, 2019 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, announced the first treatments in the AIRFLOW-3 pivotal trial, the first interventional COPD trial to target reduction in COPD …

Nuvaira Frequently Asked Questions

  • When was Nuvaira founded?

    Nuvaira was founded in 2008.

  • Who are Nuvaira key executives?

    Nuvaira's key executives are Jon Root, Gary Rieschel and Mike Carusi.

  • How many employees does Nuvaira have?

    Nuvaira has 51 employees.

  • Who are Nuvaira competitors?

    Competitors of Nuvaira include TFF Pharmaceuticals, Lung Therapeutics and Albumedix.

  • Where is Nuvaira headquarters?

    Nuvaira headquarters is located at 3750 Annapolis Ln N #105, Plymouth.

  • Where are Nuvaira offices?

    Nuvaira has offices in Plymouth and Maple Grove.

  • How many offices does Nuvaira have?

    Nuvaira has 2 offices.